Philip Ngai, MD
Ophthalmology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 4 carriers
- Office
- 1
- Since medical school
- 13 years
- University of California, Irvine, California College of Medicine, 2013
Offices
1 location
Hospitals listed: Emanate Health Inter-Community Hospital · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
21 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ngai’s office at (650) 839-2020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Oct 29, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Oct 29, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Oct 29, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A135894 · Current
Licensed to practise in California · since 2015 · expires 2029-01-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- San Gabriel Valley Surgical Center, LP dba San Gabriel Valley Surgical CenterAmbulatory Surgery Center · West Covina, CA1.5% owner since 2021 · accredited by AAAHCAccreditation Renewed5 inspections, 2 with deficiencies · last 2024-08-01: Requirements Met
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Emanate Health Inter-Community HospitalCovina, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Emanate Health, which runs 3 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Emanate Health Inter-Community Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.4 (0.39 to 2.4) · 990 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.53 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.56 (145.92 to 251.21) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 665 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.3 · 389 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 3,599 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,844 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.42) · 6,958 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.21 (0.98 to 5.43) · 1,118 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.46 (0 to 3.08) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (0.53 to 3.58) · 1,140 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.68 (1.69 to 15.67) · 450 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.07 (1.14 to 9) · 397 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 0.97) · 5,698 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 213 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.578 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.853 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.438 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.205 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 352 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 631 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2 · 136 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 336 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.2 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,007 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.5 to 8) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (8.8 to 16.5) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.6) · 113 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 106 cases | No different | Jan 2024 – Dec 2024 |
What patients said (924 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$1,052,168
Medicare paid this office $1,052,168 for 1,475 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 984 | $278,688 | $146 |
| Return visit (30+ min) | 619 | $104,552 | $107 |
| Exam of visual field with extended testing | 887 | $97,400 | $59 |
| Exam of the internal drainage system of eye | 1,282 | $73,920 | $25 |
| Imaging of retina | 1,233 | $71,802 | $35 |
See all 29 services
| Long return visit (40+ min) | 984 | $278,688 | $146 |
| Return visit (30+ min) | 619 | $104,552 | $107 |
| Exam of visual field with extended testing | 887 | $97,400 | $59 |
| Exam of the internal drainage system of eye | 1,282 | $73,920 | $25 |
| Imaging of retina | 1,233 | $71,802 | $35 |
| Complex removal of cataract with insertion of prosthetic lens | 65 | $69,581 | $656 |
| Extended exam of the back part of the eye with retinal drawing | 1,393 | $65,090 | $22 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 1,293 | $38,163 | $14 |
| Complex extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 25 | $31,760 | $775 |
| Removal of recurring cataract in lens capsule using a laser | 67 | $26,955 | $310 |
| New patient visit (45+ min) | 219 | $26,410 | $121 |
| Imaging of optic nerve | 648 | $25,327 | $31 |
| Closure of tear duct opening using plug | 51 | $14,864 | $101 |
| Established patient complete exam of visual system | 125 | $14,375 | $104 |
| Dilation of fluid outflow drainage within eye | 29 | $13,580 | $289 |
| New patient visit (60+ min) | 76 | $12,839 | $169 |
| Exam to measure eye deviation and range of motion | 79 | $9,659 | $56 |
| Removal of cataract with insertion of prosthetic lens | 15 | $9,323 | $466 |
| Multiple measurements of eye fluid pressure over an extended time period | 68 | $8,544 | $81 |
| Measurement of corneal curvature and depth of eye | 123 | $6,973 | $21 |
| Laser repair to improve eye fluid flow | 15 | $6,532 | $218 |
| Photography of the retina | 185 | $6,511 | $32 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 13 | $6,302 | $274 |
| Ct scan of cornea | 149 | $5,399 | $33 |
| Extended exam of the back part of the eye with optic nerve drawing | 230 | $3,832 | $13 |
| Ultrasound scan of cornea to determine thickness | 361 | $3,625 | $10 |
| Photography of content of eyes | 27 | $709 | $22 |
| 1d and 2d ultrasound scan of eye tissue and structures | 11 | $603 | $55 |
| Removal of eyelashes using forceps | 22 | $559 | $17 |
Procedures Medicare counted
| Cataract surgery | 322 | More than 90% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Complex removal of cataract with insertion of prosthetic lens | 51 | 72 | 157 | 169 | 148 | 106 |
| Removal of recurring cataract in lens capsule using a laser | 50 | 51 | 122 | 134 | 95 | 87 |
| Closure of tear duct opening using plug | – | – | – | – | 195 | 147 |
| Dilation of fluid outflow drainage within eye | – | 42 | 85 | 87 | 60 | 47 |
| Removal of cataract with insertion of prosthetic lens | 71 | 71 | 77 | 35 | 15 | 20 |
| Laser repair to improve eye fluid flow | – | 30 | 48 | 61 | 81 | 30 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,475 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 16% · Women 63% · Also on Medicaid 31% · Health risk score 1.26. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 42% · Chronic kidney disease 28% · Coronary heart disease 26% · Heart failure 18% · Cancer 14% · Depression 14% · Atrial fibrillation 13% · COPD 10% · Stroke 8% · Dementia 6%.
The office billed $4,405,715, Medicare allowed $1,392,111 and paid $1,052,168; for 18,812 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,475 | 18,812 | 76 | 1.26 | $4,405,715 | $1,052,168 |
| 2023 | 1,477 | 18,857 | 75 | 1.24 | $5,200,624 | $1,240,244 |
| 2022 | 1,367 | 17,590 | 75 | 1.17 | $4,948,486 | $1,192,814 |
| 2021 | 1,076 | 13,800 | 75 | 1.28 | $4,266,680 | $1,029,852 |
| 2020 | 572 | 5,634 | 76 | 1.60 | $1,985,000 | $435,295 |
| 2019 | 546 | 6,536 | 76 | 1.65 | $1,589,370 | $428,981 |
| 2018 | 376 | 1,511 | 75 | 1.65 | $324,650 | $117,623 |
| 2017 | 100 | 227 | 76 | 1.47 | $106,200 | $14,475 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 28 services
| Long return visit (40+ min) | 1,030 | $325,595 | $149 |
| Exam of visual field with extended testing | 936 | $110,497 | $58 |
| Established patient complete exam of visual system | 559 | $98,749 | $110 |
| Complex removal of cataract with insertion of prosthetic lens | 95 | $98,337 | $664 |
| Exam of the internal drainage system of eye | 1,247 | $85,535 | $25 |
| Extended exam of the back part of the eye with retinal drawing | 1,448 | $85,485 | $22 |
| Imaging of retina | 1,263 | $77,098 | $35 |
| Return visit (30+ min) | 353 | $50,960 | $111 |
| Complex extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 35 | $38,477 | $770 |
| New patient visit (45+ min) | 283 | $36,761 | $130 |
| Imaging of optic nerve | 750 | $34,002 | $31 |
| Removal of recurring cataract in lens capsule using a laser | 67 | $29,030 | $306 |
| Closure of tear duct opening using plug | 75 | $19,903 | $102 |
| Laser repair to improve eye fluid flow | 32 | $17,894 | $221 |
| Dilation of fluid outflow drainage within eye | 38 | $17,472 | $291 |
| Multiple measurements of eye fluid pressure over an extended time period | 83 | $12,586 | $82 |
| New patient visit (60+ min) | 71 | $11,868 | $167 |
| Exam to measure eye deviation and range of motion | 74 | $9,769 | $57 |
| Measurement of corneal curvature and depth of eye | 148 | $8,221 | $22 |
| Removal of excessive skin and fat of upper eyelid | 11 | $7,652 | $696 |
| Removal of cataract with insertion of prosthetic lens | 13 | $7,040 | $469 |
| Photography of the retina | 159 | $6,327 | $33 |
| Ct scan of cornea | 161 | $6,105 | $33 |
| Ultrasound scan of cornea to determine thickness | 365 | $3,622 | $10 |
| Removal of growth of eyelid | 11 | $3,054 | $254 |
| Photography of content of eyes | 58 | $1,638 | $21 |
| Removal of eyelashes using forceps | 29 | $1,202 | $20 |
| Exam of visual field with intermediate testing | 15 | $630 | $42 |
2022: 25 services
| Long return visit (40+ min) | 932 | $288,537 | $149 |
| Return visit (30+ min) | 727 | $132,429 | $108 |
| Complex removal of cataract with insertion of prosthetic lens | 102 | $109,652 | $649 |
| Exam of visual field with extended testing | 807 | $91,632 | $57 |
| Extended exam of the back part of the eye with retinal drawing | 1,319 | $81,877 | $22 |
| Imaging of retina | 1,213 | $75,462 | $35 |
| Exam of the internal drainage system of eye | 1,115 | $70,665 | $25 |
| Complex extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 46 | $60,972 | $772 |
| Removal of recurring cataract in lens capsule using a laser | 104 | $41,040 | $306 |
| New patient visit (45+ min) | 311 | $38,918 | $125 |
| Dilation of fluid outflow drainage within eye | 47 | $33,557 | $386 |
| Imaging of optic nerve | 646 | $28,389 | $31 |
| Multiple measurements of eye fluid pressure over an extended time period | 141 | $18,741 | $82 |
| Removal of cataract with insertion of prosthetic lens | 22 | $16,262 | $465 |
| Laser repair to improve eye fluid flow | 19 | $13,972 | $229 |
| Measurement of corneal curvature and depth of eye | 173 | $11,141 | $24 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $8,061 | $288 |
| Ultrasound scan of cornea to determine thickness | 754 | $7,981 | $10 |
| Exam to measure eye deviation and range of motion | 65 | $7,961 | $56 |
| New patient visit (60+ min) | 44 | $6,859 | $156 |
| Established patient complete exam of visual system | 53 | $6,778 | $115 |
| Ct scan of cornea | 176 | $5,745 | $31 |
| Photography of the retina | 109 | $3,515 | $31 |
| Photography of content of eyes | 45 | $1,259 | $22 |
| Removal of eyelashes using forceps | 21 | $887 | $21 |
2021: 25 services
| Long return visit (40+ min) | 732 | $239,730 | $157 |
| Return visit (30+ min) | 522 | $109,385 | $114 |
| Complex removal of cataract with insertion of prosthetic lens | 98 | $88,647 | $565 |
| Exam of visual field with extended testing | 655 | $76,621 | $59 |
| Dilation of fluid outflow drainage within eye | 47 | $71,315 | $839 |
| New patient visit (45+ min) | 432 | $63,449 | $147 |
| Imaging of retina | 870 | $61,009 | $35 |
| Extended exam of the back part of the eye with retinal drawing | 952 | $56,090 | $22 |
| Exam of the internal drainage system of eye | 921 | $51,630 | $25 |
| Removal of recurring cataract in lens capsule using a laser | 99 | $37,528 | $308 |
| Removal of cataract with insertion of prosthetic lens | 48 | $28,693 | $373 |
| Internal insertion of eye fluid drainage device | 45 | $23,657 | $296 |
| Imaging of optic nerve | 433 | $18,365 | $32 |
| Multiple measurements of eye fluid pressure over an extended time period | 132 | $16,269 | $80 |
| Laser repair to improve eye fluid flow | 17 | $10,670 | $222 |
| Measurement of corneal curvature and depth of eye | 144 | $9,904 | $25 |
| Photography of the retina | 246 | $9,385 | $37 |
| Exam to measure eye deviation and range of motion | 60 | $7,268 | $54 |
| New patient visit (60+ min) | 35 | $6,959 | $199 |
| Ct scan of cornea | 150 | $4,731 | $31 |
| Ultrasound scan of cornea to determine thickness | 408 | $4,175 | $10 |
| Extended exam of the back part of the eye with optic nerve drawing | 212 | $4,033 | $14 |
| Established patient complete exam of visual system | 28 | $3,555 | $111 |
| Photography of content of eyes | 58 | $1,465 | $21 |
| Removal of eyelashes using forceps | 20 | $1,181 | $27 |
2020: 25 services
| Long return visit (40+ min) | 386 | $74,642 | $123 |
| Complex removal of cataract with insertion of prosthetic lens | 44 | $40,365 | $561 |
| Established patient complete exam of visual system | 265 | $35,830 | $109 |
| Dilation of fluid outflow drainage within eye | 24 | $35,645 | $849 |
| Return visit (30+ min) | 220 | $34,456 | $94 |
| Exam of visual field with extended testing | 380 | $32,739 | $57 |
| Removal of cataract with insertion of prosthetic lens | 43 | $28,202 | $397 |
| Imaging of retina | 418 | $20,422 | $34 |
| Exam of the internal drainage system of eye | 370 | $16,459 | $25 |
| Internal insertion of eye fluid drainage device | 38 | $16,357 | $244 |
| Removal of recurring cataract in lens capsule using a laser | 42 | $15,190 | $298 |
| New patient visit (45+ min) | 101 | $12,975 | $128 |
| Extended exam of the back part of the eye with retinal drawing | 334 | $12,877 | $22 |
| Imaging of optic nerve | 246 | $9,270 | $31 |
| Photography of the retina | 179 | $7,351 | $39 |
| Laser repair to improve eye fluid flow | 16 | $6,615 | $220 |
| Measurement of corneal curvature and depth of eye | 88 | $6,288 | $28 |
| Extended exam of the back part of the eye with optic nerve drawing | 284 | $5,583 | $14 |
| Exam to measure eye deviation and range of motion | 31 | $3,258 | $55 |
| New patient visit (60+ min) | 13 | $1,829 | $141 |
| Established patient problem focused exam of visual system | 11 | $1,608 | $80 |
| Ultrasound scan of cornea to determine thickness | 140 | $1,378 | $10 |
| Ct scan of cornea | 28 | $867 | $31 |
| Photography of content of eyes | 26 | $688 | $19 |
| Removal of eyelashes using forceps | 13 | $629 | $35 |
2019: 23 services
| Established patient complete exam of visual system | 343 | $61,289 | $112 |
| Removal of cataract with insertion of prosthetic lens | 49 | $40,775 | $574 |
| New patient visit (45+ min) | 281 | $37,369 | $133 |
| Complex removal of cataract with insertion of prosthetic lens | 39 | $36,259 | $711 |
| Long return visit (40+ min) | 226 | $36,211 | $128 |
| Return visit (30+ min) | 226 | $35,291 | $96 |
| Examination of eye by ophthalmoscope with retinal drawing | 413 | $27,445 | $25 |
| Exam of visual field with extended testing | 312 | $25,995 | $59 |
| Examination of eye by ophthalmoscope with retinal drawing | 294 | $20,336 | $23 |
| Photography of the retina | 372 | $17,855 | $46 |
| Exam of the internal drainage system of eye | 400 | $15,919 | $25 |
| Imaging of retina | 270 | $11,502 | $36 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $9,378 | $303 |
| Imaging of optic nerve | 226 | $8,697 | $32 |
| Measurement of corneal curvature and depth of eye | 90 | $6,989 | $37 |
| Removal of recurring cataract in lens capsule using a laser | 14 | $5,149 | $271 |
| Ultrasound scan of cornea to determine thickness | 386 | $4,228 | $11 |
| Internal insertion of eye fluid drainage device | 14 | $3,909 | $186 |
| Established patient problem focused exam of visual system | 35 | $3,592 | $75 |
| New patient visit (60+ min) | 19 | $3,297 | $174 |
| Exam to measure eye deviation and range of motion | 11 | $1,511 | $56 |
| Removal of eyelashes using forceps | 16 | $1,389 | $39 |
| Photography of content of eyes | 11 | $316 | $19 |
2018: 14 services
| New patient visit (45+ min) | 248 | $34,348 | $138 |
| Removal of cataract with insertion of prosthetic lens | 30 | $22,636 | $566 |
| Established patient problem focused exam of visual system | 121 | $10,803 | $73 |
| Examination of eye by ophthalmoscope with retinal drawing | 186 | $8,989 | $24 |
| Photography of the retina | 166 | $8,583 | $52 |
| Established patient complete exam of visual system | 45 | $4,669 | $102 |
| Exam of the internal drainage system of eye | 164 | $4,082 | $23 |
| Exam of visual field with extended testing | 58 | $3,384 | $58 |
| Measurement of corneal curvature and depth of eye | 41 | $3,184 | $60 |
| Creation of eye fluid drainage tract for treatment of glaucoma | 16 | $2,364 | $148 |
| Examination of eye by ophthalmoscope with retinal drawing | 28 | $1,122 | $21 |
| Established patient complete exam of visual system | 17 | $993 | $58 |
| Imaging of optic nerve | 22 | $519 | $23 |
| Established patient problem focused exam of visual system | 11 | $444 | $37 |
2017: 4 services
| Established patient complete exam of visual system | 48 | $4,876 | $102 |
| Established patient problem focused exam of visual system | 42 | $3,150 | $72 |
| Examination of eye by ophthalmoscope with retinal drawing | 32 | $1,283 | $21 |
| Imaging of optic nerve | 31 | $922 | $30 |
Medicaid work
$58,154 in 2024
Medicaid paid $58,154 for 2,415 billed services this clinician did in 2024, up to 70 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 265 | $15,834 |
| Return visit (30+ min) | 180 | $9,137 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 386 | $9,014 |
| Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral | 536 | $8,258 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 215 | $5,258 |
| GONIOSCOPY | 451 | $4,982 |
| New patient visit (45+ min) | 20 | $2,492 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 53 | $1,464 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 253 | $645 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 14 | $598 |
| DETERMINATION REFRACTIVE STATE | 27 | $374 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 15 | $98 |
| 2024 | 2,415 | 12 | 70 | $58,154 |
| 2023 | 3,149 | 11 | 80 | $25,193 |
| 2022 | 1,785 | 8 | 47 | $14,820 |
| 2021 | 873 | 7 | 34 | $8,828 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 446 | $6,151 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 462 | $3,898 |
| GONIOSCOPY | 721 | $3,551 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 388 | $3,411 |
| Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral | 675 | $2,515 |
| New patient visit (45+ min) | 52 | $1,991 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 235 | $1,804 |
| Return visit (30+ min) | 34 | $678 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 105 | $605 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 19 | $474 |
| DETERMINATION REFRACTIVE STATE | 12 | $115 |
2022
| Long return visit (40+ min) | 262 | $11,337 |
| Return visit (30+ min) | 34 | $960 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 209 | $717 |
| Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral | 480 | $568 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 277 | $568 |
| GONIOSCOPY | 359 | $464 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 60 | $126 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 104 | $80 |
2021
| Long return visit (40+ min) | 130 | $6,151 |
| Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral | 261 | $757 |
| Return visit (30+ min) | 30 | $628 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 158 | $503 |
| GONIOSCOPY | 174 | $402 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 107 | $350 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 13 | $38 |
Drugs they prescribed that Part D paid
$341,542
Pharmacies billed $341,542 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,513) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
2,205 generic and 1,308 brand-name prescriptions · $341,542 in drug cost · 15 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 61 | $48,417 | $794 |
| Rhopressa | 78 | $37,691 | $483 |
| Cyclosporine | 106 | $35,449 | $334 |
| Vyzulta | 61 | $32,551 | $534 |
| Lumigan | 47 | $32,308 | $687 |
See all 28 drugs
| Restasis | 61 | $48,417 | $794 |
| Rhopressa | 78 | $37,691 | $483 |
| Cyclosporine | 106 | $35,449 | $334 |
| Vyzulta | 61 | $32,551 | $534 |
| Lumigan | 47 | $32,308 | $687 |
| Xiidra | 26 | $20,024 | $770 |
| Combigan | 31 | $17,685 | $570 |
| Latanoprost | 1,089 | $15,998 | $15 |
| Rocklatan | 22 | $12,078 | $549 |
| Dorzolamide-Timolol | 437 | $10,543 | $24 |
| Alphagan P | 14 | $9,561 | $683 |
| Brimonidine | 285 | $7,877 | $28 |
| Azelastine | 259 | $7,260 | $28 |
| Dorzolamide-Timolol | 61 | $6,313 | $103 |
| Prednisolone Acetate | 92 | $4,539 | $49 |
| Difluprednate | 40 | $3,798 | $95 |
| Brinzolamide | 14 | $2,909 | $208 |
| Dexamethasone Sodium Phosphate | 40 | $2,759 | $69 |
| Loteprednol Etabonate | 18 | $2,702 | $150 |
| Timolol Maleate | 121 | $2,415 | $20 |
| Neomycin-Polymyxin-Dexameth | 200 | $2,203 | $11 |
| Brimonidine Tartrate-Timolol | 14 | $2,128 | $152 |
| Dorzolamide | 104 | $2,092 | $20 |
| Tafluprost | 12 | $1,746 | $145 |
| Moxifloxacin | 27 | $1,361 | $50 |
| Erythromycin | 89 | $883 | $10 |
| Ofloxacin | 48 | $623 | $13 |
| Ketorolac Tromethamine | 13 | $312 | $24 |
Year by year
| 2024 | 3,513 | 734 | 0% (0) | 37% | $341,542 |
| 2023 | 3,063 | 639 | 0% (0) | 35% | $368,151 |
| 2022 | 2,831 | 563 | 0% (0) | 34% | $362,840 |
| 2021 | 2,875 | 551 | 0% (0) | 38% | $360,096 |
| 2020 | 2,573 | 422 | 0% (0) | 39% | $311,534 |
| 2019 | 1,906 | 363 | 0% (0) | 40% | $217,763 |
| 2018 | 298 | 98 | 0% (0) | 39% | $14,395 |
| 2017 | 85 | 38 | None | 18% | $5,906 |
| 2016 | 238 | 91 | None | 39% | $23,480 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Restasis | 65 | $70,133 | $1,079 |
| Vyzulta | 73 | $39,414 | $540 |
| Lumigan | 40 | $31,396 | $785 |
| Rhopressa | 50 | $27,339 | $547 |
| Latanoprost | 980 | $22,871 | $23 |
| Cyclosporine | 29 | $20,831 | $718 |
| Combigan | 49 | $20,768 | $424 |
| Xiidra | 20 | $15,442 | $772 |
| Dorzolamide-Timolol | 319 | $12,969 | $41 |
| Alphagan P | 23 | $12,823 | $558 |
| Simbrinza | 34 | $12,226 | $360 |
| Dorzolamide-Timolol | 68 | $11,256 | $166 |
| Azelastine | 242 | $9,041 | $37 |
| Brimonidine | 192 | $8,113 | $42 |
| Difluprednate | 30 | $4,517 | $151 |
| Dorzolamide | 114 | $3,827 | $34 |
| Prednisolone Acetate | 65 | $3,745 | $58 |
| Loteprednol Etabonate | 18 | $3,452 | $192 |
| Neomycin-Polymyxin-Dexameth | 229 | $3,185 | $14 |
| Dexamethasone Sodium Phosphate | 37 | $2,740 | $74 |
| Timolol Maleate | 99 | $2,306 | $23 |
| Olopatadine | 34 | $1,605 | $47 |
| Erythromycin | 100 | $1,112 | $11 |
| Ofloxacin | 37 | $685 | $19 |
| Ketorolac Tromethamine | 12 | $313 | $26 |
2022: 27 drugs
| Restasis | 60 | $72,994 | $1,217 |
| Rhopressa | 49 | $34,831 | $711 |
| Vyzulta | 49 | $29,850 | $609 |
| Lumigan | 45 | $29,550 | $657 |
| Combigan | 47 | $19,963 | $425 |
| Latanoprost | 842 | $19,495 | $23 |
| Dorzolamide-Timolol | 338 | $17,507 | $52 |
| Alphagan P | 26 | $14,303 | $550 |
| Simbrinza | 42 | $12,035 | $287 |
| Azelastine | 231 | $11,911 | $52 |
| Rocklatan | 15 | $10,516 | $701 |
| Xiidra | 11 | $6,786 | $617 |
| Difluprednate | 39 | $6,455 | $166 |
| Brimonidine | 165 | $5,548 | $34 |
| Loteprednol Etabonate | 26 | $5,180 | $199 |
| Alrex | 13 | $5,128 | $394 |
| Prednisolone Acetate | 66 | $4,340 | $66 |
| Durezol | 15 | $3,336 | $222 |
| Dorzolamide | 74 | $2,693 | $36 |
| Neomycin-Polymyxin-Dexameth | 207 | $2,673 | $13 |
| Olopatadine | 82 | $2,469 | $30 |
| Timolol Maleate | 85 | $2,455 | $29 |
| Dexamethasone Sodium Phosphate | 32 | $1,887 | $59 |
| Tobramycin-Dexamethasone | 12 | $1,359 | $113 |
| Ofloxacin | 57 | $700 | $12 |
| Erythromycin | 59 | $535 | $9 |
| Ketorolac Tromethamine | 11 | $467 | $42 |
2021: 29 drugs
| Restasis | 52 | $55,129 | $1,060 |
| Durezol | 186 | $40,365 | $217 |
| Rhopressa | 54 | $35,842 | $664 |
| Lumigan | 40 | $24,645 | $616 |
| Combigan | 34 | $18,700 | $550 |
| Latanoprost | 709 | $16,704 | $24 |
| Vyzulta | 31 | $15,790 | $509 |
| Dorzolamide-Timolol | 245 | $15,486 | $63 |
| Alphagan P | 22 | $14,322 | $651 |
| Rocklatan | 24 | $9,517 | $397 |
| Prolensa | 26 | $9,411 | $362 |
| Olopatadine | 191 | $9,241 | $48 |
| Prednisolone Acetate | 122 | $7,498 | $61 |
| Simbrinza | 13 | $6,454 | $496 |
| Alrex | 24 | $6,070 | $253 |
| Loteprednol Etabonate | 30 | $5,378 | $179 |
| Azelastine | 90 | $5,267 | $59 |
| Travatan Z | 14 | $4,943 | $353 |
| Brimonidine | 146 | $4,454 | $31 |
| Dorzolamide | 91 | $4,117 | $45 |
| Ilevro | 11 | $3,545 | $322 |
| Pazeo | 11 | $3,253 | $296 |
| Ofloxacin | 250 | $3,070 | $12 |
| Neomycin-Polymyxin-Dexameth | 191 | $2,620 | $14 |
| Difluprednate | 15 | $2,395 | $160 |
| Pilocarpine | 19 | $1,440 | $76 |
| Timolol Maleate | 62 | $1,372 | $22 |
| Dexamethasone Sodium Phosphate | 22 | $1,146 | $52 |
| Erythromycin | 33 | $406 | $12 |
2020: 30 drugs
| Pazeo | 182 | $47,202 | $259 |
| Durezol | 199 | $40,419 | $203 |
| Restasis | 36 | $29,577 | $822 |
| Rhopressa | 41 | $22,817 | $557 |
| Lumigan | 38 | $20,819 | $548 |
| Combigan | 53 | $20,561 | $388 |
| Dorzolamide-Timolol | 222 | $13,374 | $60 |
| Latanoprost | 592 | $12,164 | $21 |
| Travatan Z | 36 | $11,949 | $332 |
| Vyzulta | 23 | $11,118 | $483 |
| Simbrinza | 24 | $7,256 | $302 |
| Xiidra | 12 | $7,189 | $599 |
| Alphagan P | 17 | $6,954 | $409 |
| Azopt | 11 | $5,851 | $532 |
| Brimonidine | 172 | $5,153 | $30 |
| Olopatadine | 86 | $4,369 | $51 |
| Alrex | 11 | $4,178 | $380 |
| Prednisolone Acetate | 86 | $4,105 | $48 |
| Loteprednol Etabonate | 14 | $3,814 | $272 |
| Travoprost | 12 | $3,665 | $305 |
| Dorzolamide | 86 | $3,510 | $41 |
| Ofloxacin | 205 | $2,370 | $12 |
| Neomycin-Polymyxin-Dexameth | 140 | $2,241 | $16 |
| Timolol Maleate | 59 | $1,926 | $33 |
| Acetazolamide Er | 11 | $1,909 | $174 |
| Tobramycin-Dexamethasone | 14 | $1,664 | $119 |
| Azelastine | 34 | $1,130 | $33 |
| Dexamethasone Sodium Phosphate | 12 | $660 | $55 |
| Erythromycin | 43 | $531 | $12 |
| Sulfacetamide-Prednisolone | 14 | $224 | $16 |
2019: 23 drugs
| Restasis | 35 | $29,555 | $844 |
| Pazeo | 79 | $21,373 | $271 |
| Lumigan | 45 | $18,424 | $409 |
| Durezol | 97 | $18,400 | $190 |
| Travatan Z | 38 | $18,050 | $475 |
| Combigan | 69 | $17,409 | $252 |
| Rhopressa | 30 | $10,798 | $360 |
| Vyzulta | 27 | $9,283 | $344 |
| Dorzolamide-Timolol | 179 | $8,354 | $47 |
| Latanoprost | 394 | $8,188 | $21 |
| Prednisolone Acetate | 154 | $7,650 | $50 |
| Alrex | 22 | $5,926 | $269 |
| Lotemax | 16 | $4,866 | $304 |
| Simbrinza | 19 | $4,465 | $235 |
| Brimonidine | 115 | $3,594 | $31 |
| Ofloxacin | 167 | $2,488 | $15 |
| Dorzolamide | 81 | $2,450 | $30 |
| Olopatadine | 34 | $2,381 | $70 |
| Neomycin-Polymyxin-Dexameth | 100 | $1,875 | $19 |
| Fluorometholone | 18 | $1,292 | $72 |
| Timolol Maleate | 52 | $755 | $15 |
| Azelastine | 13 | $521 | $40 |
| Erythromycin | 26 | $334 | $13 |
2018: 7 drugs
| Prednisolone Acetate | 64 | $2,836 | $44 |
| Brimonidine | 24 | $1,685 | $70 |
| Latanoprost | 62 | $1,003 | $16 |
| Ofloxacin | 51 | $705 | $14 |
| Dorzolamide-Timolol | 23 | $425 | $18 |
| Dorzolamide | 18 | $276 | $15 |
| Timolol Maleate | 14 | $84 | $6 |
2017: 1 drug
| Latanoprost | 29 | $495 | $17 |
2016: 7 drugs
| Restasis | 20 | $8,465 | $423 |
| Cosopt Pf | 12 | $1,739 | $145 |
| Prednisolone Acetate | 27 | $1,526 | $57 |
| Dorzolamide-Timolol | 28 | $931 | $33 |
| Latanoprost | 50 | $683 | $14 |
| Ofloxacin | 13 | $195 | $15 |
| Brimonidine | 11 | $160 | $15 |
Money from drug and device companies
$4,358 in 2025
| 2025 | 12 | 39 | $2,400 | $4,358 |
| 2024 | 10 | 28 | $6,156 | $7,111 |
| 2023 | 7 | 25 | $6,000 | $7,309 |
| 2022 | 4 | 24 | $8,000 | $9,180 |
| 2021 | 6 | 31 | $3,000 | $4,031 |
| 2020 | 8 | 30 | $3,500 | $4,303 |
| 2019 | 6 | 11 | None | $452 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Glaukos | Idosetr | $2,739 | 3 payments
|
| Abbvie | Durysta | $465 | 6 payments
|
| Alcon Vision | Clareon | $420 | 14 payments
|
| Sight Sciences | Omni Surgical System | $267 | 5 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $198 | 3 payments
|
| Nova Eye | None | $77 | 1 payment
|
See all 39 published payments
| Alcon Vision | Meals · 2025-12-10 | Clareon | $23 |
| Sun Pharmaceutical Industries | Meals · 2025-11-12 | Cequa | $29 |
| Abbvie | Meals · 2025-11-03 | Durysta | $147 |
| Alcon Vision | Meals · 2025-10-31 | Rocklatan | $8 |
| Fusion Orthopedics USA | Meals · 2025-10-22 | None | $38 |
| Alcon Vision | Meals · 2025-10-08 | Clareon | $76 |
| Glaukos | Consulting · 2025-10-01 | None | $2,400 |
| Alcon Vision | Meals · 2025-09-26 | Rocklatan | $13 |
| Alcon Vision | Meals · 2025-09-26 | Tryptyr | $30 |
| Abbvie | Meals · 2025-09-24 | Durysta | $125 |
| New World Medical | Meals · 2025-09-24 | Kahook Dual Blade | $21 |
| Abbvie | Meals · 2025-09-22 | Durysta | $128 |
| Rayner Intraocular Lenses | Meals · 2025-09-12 | Omidria | $29 |
| Alcon Vision | Meals · 2025-08-22 | Rocklatan | $7 |
| Alcon Vision | Meals · 2025-08-14 | Clareon | $34 |
| Alcon Vision | Meals · 2025-08-07 | Clareon | $3 |
| RxSight | Meals · 2025-07-11 | Rxsight Contact Lens | $18 |
| Oyster Point Pharma | Meals · 2025-07-09 | Tyrvaya | $26 |
| RxSight | Meals · 2025-06-17 | Rxsight Contact Lens | $32 |
| Alcon Vision | Meals · 2025-05-28 | Hydrus Microstent | $45 |
| Alcon Vision | Meals · 2025-04-27 | Clareon | $63 |
| Glaukos | Meals · 2025-04-26 | Idosetr | $155 |
| Sight Sciences | Meals · 2025-04-24 | Omni Surgical System | $6 |
| Sight Sciences | Meals · 2025-04-24 | Omni Surgical System | $141 |
| Nova Eye | Meals · 2025-04-21 | None | $77 |
| Alcon Vision | Meals · 2025-03-15 | Rocklatan | $35 |
| Abbvie | Meals · 2025-03-13 | Xen Glaucoma Treatment System | $11 |
| Tarsus Pharmaceuticals | Meals · 2025-03-12 | Xdemvy | $36 |
| Abbvie | Meals · 2025-03-08 | Durysta | $33 |
| Alcon Vision | Meals · 2025-03-07 | Rocklatan | $5 |
| Sight Sciences | Meals · 2025-02-27 | Omni Surgical System | $97 |
| Glaukos | Meals · 2025-02-26 | Idosetr | $184 |
| Tarsus Pharmaceuticals | Meals · 2025-02-20 | Xdemvy | $25 |
| Sight Sciences | Meals · 2025-02-20 | Omni Surgical System | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-01-30 | Xdemvy | $137 |
| Abbvie | Meals · 2025-01-29 | Durysta | $21 |
| Sight Sciences | Meals · 2025-01-14 | Omni Surgical System | $14 |
| Alcon Vision | Meals · 2025-01-10 | Hydrus Microstent | $57 |
| Alcon Vision | Meals · 2025-01-07 | Hydrus Microstent | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $7,111
| Sight Sciences | Omni Surgical System | $4,805 | 9 payments
|
| Alcon Research | None | $1,650 | 1 payment
|
| Alcon Vision | Hydrus Microstent | $327 | 8 payments
|
| Abbvie | Xen Glaucoma Treatment System | $112 | 3 payments
|
| Nova Eye | None | $88 | 1 payment
|
| Carl Zeiss Meditec USA | Lumera 700 | $38 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $26 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $25 | 1 payment
|
| Amgen | Tepezza | $23 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $16 | 1 payment
|
2023: $7,309
| Sight Sciences | Omni Surgical System | $6,519 | 12 payments
|
| Alcon Vision | Hydrus Microstent | $336 | 7 payments
|
| Biotissue Holdings | Prokera | $150 | 1 payment
|
| Genentech USA | None | $149 | 1 payment
|
| Abbvie | Xen Glaucoma Treatment System | $85 | 2 payments
|
| Bausch & Lomb Americas | Envista Mx60 Iol | $56 | 1 payment
|
| Thea Pharma | Iyuzeh | $13 | 1 payment
|
2022: $9,180
| Sight Sciences | Omni(R) Surgical System (US) | $9,011 | 20 payments
|
| Glaukos | Iaccess | $88 | 1 payment
|
| Abbvie | Xen Glaucoma Treatment System | $68 | 2 payments
|
| Alcon Vision | Hydrus Microstent | $13 | 1 payment
|
2021: $4,031
| Ivantis | Hydrus Microstent | $3,696 | 17 payments
|
| Allergan | Xen Glaucoma Treatment System | $228 | 8 payments
|
| Alcon Vision | Argos | $42 | 2 payments
|
| Sight Sciences | Omni(R) Surgical System (US) | $31 | 2 payments
|
| Aerie Pharmaceuticals | Rhopressa | $21 | 1 payment
|
| Glaukos | Istent | $13 | 1 payment
|
2020: $4,303
| Sight Sciences | Omni | $2,148 | 4 payments
|
| Ivantis | Hydrus | $1,842 | 14 payments
|
| Glaukos | Istent Trabecular Micro-Bypass Stent System | $197 | 5 payments
|
| Aerie Pharmaceuticals | Rhopressa | $32 | 2 payments
|
| Alcon Vision | Acrysof Iq Panoptix | $32 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $20 | 1 payment
|
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
| Allergan | Xen | $12 | 1 payment
|
2019: $452
| Aerie Pharmaceuticals | Rhopressa | $119 | 1 payment
|
| Allergan | Restasis | $117 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis 1-Piece Iol | $109 | 4 payments
|
| Glaukos | Istent Inject Trabecular Micro-Bypass Stent System | $72 | 3 payments
|
| Ivantis | Hydrus | $22 | 1 payment
|
| Optos | P200dtx | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1649614215
- Licence
- CA A135894California A135894: Current · expires 2029-01-31
- Trained
- University of California, Irvine, California College of Medicine, 2013 · 13 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0009X (207WX0009X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1250 S Sunset Ave Ste 205, West Covina, CA, 91790
- NPI first listed
- 2013-04-25
- NPI last updated
- 2018-09-19
This is when the NPI record was last certified, not a medical board exam.